Sinopharm
1099.HK
$2.61
Share price
0.99%
Change (1 day)
-25.29%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Market capitalization of Sinopharm (1099.HK)
Market cap: $8.15 Billion
As of May 2024 Sinopharm has a market cap of $8.15 Billion. This makes Sinopharm the world's 1905th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Sinopharm from 2009 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $8.15 B | -0.15% |
| 2023 | $8.17 B | 2.86% |
| 2022 | $7.94 B | 17.05% |
| 2021 | $6.78 B | -5.92% |
| 2020 | $7.21 B | -33.54% |
| 2019 | $10.85 B | -13.05% |
| 2018 | $12.48 B | 4.34% |
| 2017 | $11.96 B | 4.95% |
| 2016 | $11.40 B | 2.68% |
| 2015 | $11.10 B | 13.38% |
| 2014 | $9.79 B | 32.88% |
| 2013 | $7.36 B | -1.96% |
| 2012 | $7.51 B | 30.31% |
| 2011 | $5.76 B | -26.85% |
| 2010 | $7.88 B | -1.99% |
| 2009 | $8.04 B |
End of Day market cap according to different sources
On May 6th, 2024 the market cap of Sinopharm was reported to be:
